Health care stocks were retreating Thursday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.2% lower.
The iShares Biotechnology ETF (IBB) rose 0.1%.
In corporate news, Walgreens Boots Alliance (WBA) agreed to pay $2.8 million to settle allegations that it violated federal, Massachusetts and Georgia laws by submitting inflated prices for certain generic medications to the states' Medicaid programs, the US Attorney's Office for the District of Massachusetts said. Walgreens shares rose 0.7%.
23andMe (ME) shares surged 50% after a court authorized the company to start an asset sale process through a Chapter 11 plan or pursuant to Section 363 of the US Bankruptcy Code.
Abbott Laboratories (ABT) shares rose 3% after the company said Thursday it has received CE Mark certification in Europe for its Volt pulsed field ablation system to treat patients with heart rhythm disorders.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。